India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...

Priorities for next phase: Real-time decision-making, customer experience, sovereign control over data, and compliance.

Welcome to TrendMap, your quick, visual guide to the performance of different investment segments. In this edition, we present a 10-year pe...

Indian companies are rapidly adopting artificial intelligence. While some have fully integrated AI, many are still in pilot phases. Challen...

⁠Brookfield Asset Management, KKR and other private equity and institutional investors have been in talks to invest in the round, the repor...

A devastating fire at the Flourish Stay B&B in Malviya Nagar has claimed 21 lives, including 11 foreign nationals and 10 Indians. The blaze...

British lawmakers called Wednesday for the government to end a contract between the country's National Health Service and AI giant Palantir...

US services sector activity expanded in May, exceeding expectations with the ISM index at 54.5%. While business activity and new orders gre...

Market confusion presents a rare chance for patient investors. Anshul Saigal believes current valuations offer significant gains for those ...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...

A new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...